To evaluate the potential correlation between HMGB1 and the malignant progression of NSCLC, the HMGB1 expression in pleural effusion samples with NSCLC as well as patients’ clinicopathological features were jointly analyzed. Here, HMGB1 is linked to non-small cell lung carcinoma.